Your browser doesn't support javascript.
loading
A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation.
Yuan, Xiao-Lin; Lai, Xiao-Yu; Wu, Yi-Bo; Yang, Lu-Xin; Shi, Ji-Min; Liu, Li-Zhen; Yu, Jian; Zhao, Yan-Min; Zheng, Wei-Yan; He, Jing-Song; Sun, Jie; Wu, Wen-Jun; Zhao, Yi; Ye, Yi-Shan; Cai, Zhen; Huang, He; Luo, Yi.
Affiliation
  • Yuan XL; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Lai XY; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Wu YB; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Yang LX; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Shi JM; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Liu LZ; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Yu J; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Zhao YM; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Zheng WY; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • He JS; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Sun J; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Wu WJ; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Zhao Y; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Ye YS; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Cai Z; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Huang H; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Luo Y; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Bone Marrow Transplant ; 58(7): 801-810, 2023 07.
Article in En | MEDLINE | ID: mdl-37072477
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom